solifenacin succinate NDC 27241-037

NDC codes

FDA NDC Directory

Product NDC (as listed)27241-037Labeler and product segments. Claims need a package NDC.

Product NDC at billing width27241-0037Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
27241-037-03	27241003703	30 TABLET, FILM COATED in 1 BOTTLE (27241-037-03)Marketed from May 20, 2019
27241-037-09	27241003709	90 TABLET, FILM COATED in 1 BOTTLE (27241-037-09)Marketed from May 20, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): solifenacin succinate
Generic name (nonproprietary): solifenacin succinate
Active ingredients: Solifenacin succinate — 5 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Ajanta Pharma USA Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 205483
Marketing start: May 20, 2019
Listing expires: Dec 31, 2027
Other FDA classes: Cholinergic Muscarinic Antagonists (Mechanism)
Identifiers: Product ID 27241-037_abee70a8-6884-4748-b266-11a84236c0a1SPL ID abee70a8-6884-4748-b266-11a84236c0a1SPL set ID 9558ed7a-e942-4261-8aea-6033352f79b8RxCUI 477367, 477372UNII KKA5DLD701UPC 0327241038037, 0327241037092, 0327241038099, 0327241037030
Pharmacologic class: Cholinergic Muscarinic Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N427241003703 followed by a unit qualifier and the quantity

Package 27241-0037-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 30, 2025.

Indications (excerpt from the label)

Solifenacin succinate tablets are indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. Solifenacin succinate tablets are a muscarinic antagonist indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 205483

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 205483
Product	Strength	Form · route	Labeler	Product NDC
solifenacin succinate	Solifenacin succinate 10 mg/1	Tablet, Film coatedOral	Ajanta Pharma USA Inc.	27241-038